Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2891552rdf:typepubmed:Citationlld:pubmed
pubmed-article:2891552lifeskim:mentionsumls-concept:C0006675lld:lifeskim
pubmed-article:2891552lifeskim:mentionsumls-concept:C0024660lld:lifeskim
pubmed-article:2891552lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:2891552lifeskim:mentionsumls-concept:C0013030lld:lifeskim
pubmed-article:2891552lifeskim:mentionsumls-concept:C0028351lld:lifeskim
pubmed-article:2891552lifeskim:mentionsumls-concept:C0027908lld:lifeskim
pubmed-article:2891552lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2891552lifeskim:mentionsumls-concept:C0220839lld:lifeskim
pubmed-article:2891552lifeskim:mentionsumls-concept:C0030685lld:lifeskim
pubmed-article:2891552lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:2891552lifeskim:mentionsumls-concept:C0680255lld:lifeskim
pubmed-article:2891552lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:2891552lifeskim:mentionsumls-concept:C1283071lld:lifeskim
pubmed-article:2891552lifeskim:mentionsumls-concept:C1963578lld:lifeskim
pubmed-article:2891552lifeskim:mentionsumls-concept:C1519355lld:lifeskim
pubmed-article:2891552pubmed:issue3lld:pubmed
pubmed-article:2891552pubmed:dateCreated1988-2-8lld:pubmed
pubmed-article:2891552pubmed:abstractTextNoradrenaline and dopamine (0.1-100 microM) inhibited 45Ca2+ uptake and glutamate release induced by veratrine (25 microM) in cortical and striatal slices but were without effect when added alone. Each parameter was inhibited in a dose-dependent manner by noradrenaline in cortical slices (IC50 = 0.05 microM) and by dopamine in striatal slices (IC50 = 0.08 microM). Noradrenaline (0.01-100 microM) was without influence on veratrine-induced 45Ca2+ influx or glutamate release in the striatal preparation, and likewise dopamine was inactive in cortex slices. The use of adrenoceptor antagonists suggests that the action of noradrenaline is mediated by the alpha 2-receptor which is thought to be adenylate cyclase linked. Dopamine appeared to be acting through the D-2 receptor.lld:pubmed
pubmed-article:2891552pubmed:languageenglld:pubmed
pubmed-article:2891552pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2891552pubmed:citationSubsetIMlld:pubmed
pubmed-article:2891552pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2891552pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2891552pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2891552pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2891552pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2891552pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2891552pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2891552pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2891552pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2891552pubmed:statusMEDLINElld:pubmed
pubmed-article:2891552pubmed:monthNovlld:pubmed
pubmed-article:2891552pubmed:issn0014-2999lld:pubmed
pubmed-article:2891552pubmed:authorpubmed-author:BradfordH FHFlld:pubmed
pubmed-article:2891552pubmed:authorpubmed-author:CrowderJ MJMlld:pubmed
pubmed-article:2891552pubmed:issnTypePrintlld:pubmed
pubmed-article:2891552pubmed:day17lld:pubmed
pubmed-article:2891552pubmed:volume143lld:pubmed
pubmed-article:2891552pubmed:ownerNLMlld:pubmed
pubmed-article:2891552pubmed:authorsCompleteYlld:pubmed
pubmed-article:2891552pubmed:pagination343-52lld:pubmed
pubmed-article:2891552pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2891552pubmed:meshHeadingpubmed-meshheading:2891552-...lld:pubmed
pubmed-article:2891552pubmed:meshHeadingpubmed-meshheading:2891552-...lld:pubmed
pubmed-article:2891552pubmed:meshHeadingpubmed-meshheading:2891552-...lld:pubmed
pubmed-article:2891552pubmed:meshHeadingpubmed-meshheading:2891552-...lld:pubmed
pubmed-article:2891552pubmed:meshHeadingpubmed-meshheading:2891552-...lld:pubmed
pubmed-article:2891552pubmed:meshHeadingpubmed-meshheading:2891552-...lld:pubmed
pubmed-article:2891552pubmed:meshHeadingpubmed-meshheading:2891552-...lld:pubmed
pubmed-article:2891552pubmed:meshHeadingpubmed-meshheading:2891552-...lld:pubmed
pubmed-article:2891552pubmed:meshHeadingpubmed-meshheading:2891552-...lld:pubmed
pubmed-article:2891552pubmed:meshHeadingpubmed-meshheading:2891552-...lld:pubmed
pubmed-article:2891552pubmed:meshHeadingpubmed-meshheading:2891552-...lld:pubmed
pubmed-article:2891552pubmed:meshHeadingpubmed-meshheading:2891552-...lld:pubmed
pubmed-article:2891552pubmed:meshHeadingpubmed-meshheading:2891552-...lld:pubmed
pubmed-article:2891552pubmed:meshHeadingpubmed-meshheading:2891552-...lld:pubmed
pubmed-article:2891552pubmed:meshHeadingpubmed-meshheading:2891552-...lld:pubmed
pubmed-article:2891552pubmed:meshHeadingpubmed-meshheading:2891552-...lld:pubmed
pubmed-article:2891552pubmed:meshHeadingpubmed-meshheading:2891552-...lld:pubmed
pubmed-article:2891552pubmed:year1987lld:pubmed
pubmed-article:2891552pubmed:articleTitleInhibitory effects of noradrenaline and dopamine on calcium influx and neurotransmitter glutamate release in mammalian brain slices.lld:pubmed
pubmed-article:2891552pubmed:affiliationBiochemistry Department, Imperial College of Science and Technology, London, U.K.lld:pubmed
pubmed-article:2891552pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2891552pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2891552lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2891552lld:pubmed